glp-1-based therapy Expanding applications of therapies based on GLP1 GLP-1 Medications for Weight Loss:

Key results at the highest dose (24 mg): 22.5% placebo-adjusted mean weight loss at 48 weeks 96% achieved at least 5% weight loss 87% achieved at least 10% weight loss 48% achieved at least 20% weight loss 26% achieved at least 30% weight loss 54% reduced BMI below the obesity threshold (30 kg/m2) versus 13% placebo No weight loss plateau at 48 weeks Discontinuation due to adverse events: 5.9% (CT-388) vs 1.3% (placebo) Preclinical Data# CT-388 improved glycemic control in mice and monkeys, reduced body weight, suppressed appetite, and improved metabolic dysfunction-associated steatohepatitis (MASH) pathology in mice

Consistency matters more than intensitydaily movement outperforms occasional intense exercise

At the end of the procedure, a really good doctor will even remember to put the blood back in the body

Youre a master teacher, so instead of me saying that, why dont you go ahead and explain. Eric Topol: Well, to simplify, youre going to find out risks that you didnt think were in your family or you knew werent in your family

When consumed in standard capsule or tablet form, glutathione is rapidly broken down by digestive enzymes and stomach acid before it can reach systemic circulation